{
  "name": "Therapeutic mAb",
  "type": "INANIMATE_OBJECT",
  "id": {
    "group": 20,
    "item": 1234
  },
  "claims": [
    {
      "predicate": "IS_A",
      "object": "Monoclonal antibody",
      "temporal": {
        "valid_from": "ORIGIN",
        "valid_until": "PRESENT",
        "event": null
      },
      "epistemic": {
        "confidence": 0.9,
        "status": "SETTLED",
        "source_type": "ACADEMIC"
      }
    },
    {
      "predicate": "CAPABLE_OF",
      "object": "mediating interactions between tumor cells and immune cells",
      "temporal": {
        "valid_from": "ORIGIN",
        "valid_until": "PRESENT",
        "event": null
      },
      "epistemic": {
        "confidence": 0.8,
        "status": "SETTLED",
        "source_type": "ACADEMIC"
      }
    },
    {
      "predicate": "USED_FOR",
      "object": "engaging with immune cells",
      "temporal": {
        "valid_from": "ORIGIN",
        "valid_until": "PRESENT",
        "event": null
      },
      "epistemic": {
        "confidence": 0.85,
        "status": "SETTLED",
        "source_type": "ACADEMIC"
      }
    }
  ],
  "surface_layer": {
    "definition": "Therapeutic monoclonal antibodies are antibodies used for therapeutic purposes, specifically able to engage with immune cells.",
    "common_uses": []
  },
  "deep_layer": {
    "mechanism": null,
    "origin": null
  },
  "instance_layer": [],
  "facets": {},
  "epistemic_metadata": {
    "source": "Set Automatically",
    "citations": [
      "https://pmc.ncbi.nlm.nih.gov/articles/PMC5972536/"
    ]
  }
}